Intraoperative Neuromonitoring Market To Reach $4.66 Billion By 2030

Intraoperative Neuromonitoring Market Growth & Trends

The global intraoperative neuromonitoring market size  is expected to reach USD 4.66 billion in 2030 and is anticipated to grow at a CAGR of 5.97% over the forecast period. This growth can be attributed to technological advancements, increasing awareness regarding the safety of the devices, and the growing geriatric population. The COVID-19 outbreak is expected to have a dual impact on the market. In March 2020, the American College of Surgeons (ACS) published a proposal to reduce, postpone, or cancel elective surgeries as COVID-19 cases grew quickly in the U.S., which is expected to hamper growth.

Moreover, according to a research study published in Elsevier journal (International Hemorrhagic Stroke Association; Jan 2021), up to 36% of hospitalized COVID-19 patients might exhibit neurological symptoms, and there were several cases related to ischemic & hemorrhagic infarction. In addition, another recent research study published in Neurology Online Journal in June 2021 proposed that the COVID-19 virus might be responsible for patients acquiring novel neurological diseases. Owing to the growth of new diseases, there is a higher risk of in-hospital mortality and a low discharge rate. These characteristics are expected to result in lucrative growth over the forecast period.

Furthermore, the market is expected to witness growth due to the increasing number & affordability of neurosurgeries and the growing emphasis on patient safety in surgeries. Hospitals are adopting Intraoperative Neuromonitoring (IONM) in a wide spectrum of surgeries, as it reduces the number of revision surgeries and results in fewer postoperative complications & cases of permanent impairment.

 Request a free sample copy or view report summary: Intraoperative Neuromonitoring Market Report

Intraoperative Neuromonitoring Market Report Highlights

• By type, the insourced segment accounted for the largest share of 52.72% in 2024. This can be attributed to growing awareness among physicians as well as patients about the benefits of IONM, which results in the hospitals utilizing IONM during complex procedures. This is a key reason for the dominance of insourced IONM in the market

• By region, North America accounted for the largest share of 49.35% in 2024. Favorable reimbursement scenarios along with technological advancements can be attributed to this dominance

• The intraoperative neuromonitoring market in Europe is anticipated to grow fastest with a CAGR of 6.38% during the forecast period

Intraoperative Neuromonitoring Market Segmentation

Grand View Research has segmented the global intraoperative neuromonitoring market report on the basis of product, source, type, and region

Intraoperative Neuromonitoring Product Outlook (Revenue USD Million, 2018 - 2030)

• Systems

• Disposables

  • EMG Tubes And Electrodes

  • Sticker Electrode

  • Stimulating Probes

Intraoperative Neuromonitoring Source Outlook (Revenue USD Million, 2018 - 2030)

• Insourced

• Outsourced

Intraoperative Neuromonitoring Type Outlook (Revenue, USD Million, 2018 - 2030)

• Intermittent Monitoring

• Continuous Monitoring

Intraoperative Neuromonitoring Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Norway

  • Denmark

  • Sweden

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in Intraoperative Neuromonitoring Market

• Natus Medical Incorporated

• Accurate Monitoring

• Neuromonitoring Technologies

• Medtronic

• NuVasive, Inc.

• SpecialtyCare

• Neurosoft

• Ambu A/S

• Brainlab AG (Dr. Langer Medical GmbH)

• Welcony (Neurosign UK Ltd.)